Cortagine, a CRF1 agonist, induces stresslike alterations of colonic function and visceral hypersensitivity in rodents primarily through peripheral pathways. - Wikidata - awgldk - TriplyDB

Cortagine, a CRF1 agonist, induces stresslike alterations of colonic function and visceral hypersensitivity in rodents primarily through peripheral pathways.

Cortagine, a CRF1 agonist, induces stresslike alterations of colonic function and visceral hypersensitivity in rodents primarily through peripheral pathways.

http://www.wikidata.org/entity/Q37264524

about

Activation of corticotropin-releasing factor receptor 2 mediates the colonic motor coping response to acute stress in rodents Changes in Enteric Neurons of Small Intestine in a Rat Model of Irritable Bowel Syndrome with Diarrhea.Role of Corticotropin-releasing Factor in Gastrointestinal Permeability.Stress and visceral pain: from animal models to clinical therapies Enhanced cytokine-induced mechanical hyperalgesia in skeletal muscle produced by a novel mechanism in rats exposed to unpredictable sound stress.Corticotropin releasing factor in the rat colon: expression, localization and upregulation by endotoxin Irritable bowel syndrome: a clinical review Psychological Stress Induces Visceral Analgesic or Hyperalgesic Response in Rodents: A Role of Preconditions.Role of Corticotropin-releasing Factor Signaling in Stress-related Alterations of Colonic Motility and Hyperalgesia.The newly developed CRF1-receptor antagonists, NGD 98-2 and NGD 9002, suppress acute stress-induced stimulation of colonic motor function and visceral hypersensitivity in rats.Stress-induced visceral pain: toward animal models of irritable-bowel syndrome and associated comorbidities.Stress-related alterations of visceral sensation: animal models for irritable bowel syndrome study.Corticotropin-releasing factor signaling and visceral response to stress.Selective agonists of somatostatin receptor subtype 1 or 2 injected peripherally induce antihyperalgesic effect in two models of visceral hypersensitivity in mice Activation of Type 1 CRH receptor isoforms induces serotonin release from human carcinoid BON-1N cells: an enterochromaffin cell model.Stress-induced visceral analgesia assessed non-invasively in rats is enhanced by prebiotic diet.Corticotropin releasing factor signaling in colon and ileum: regulation by stress and pathophysiological implications A role for corticotropin-releasing factor in functional gastrointestinal disorders.Repeated psychological stress-induced alterations of visceral sensitivity and colonic motor functions in mice: influence of surgery and postoperative single housing on visceromotor responses The joint power of sex and stress to modulate brain-gut-microbiota axis and intestinal barrier homeostasis: implications for irritable bowel syndrome.Stress and the Microbiota-Gut-Brain Axis in Visceral Pain: Relevance to Irritable Bowel Syndrome.IBS and IBD - separate entities or on a spectrum?Visceral analgesia induced by acute and repeated water avoidance stress in rats: sex difference in opioid involvement.Endogenous CRF in rat large intestine mediates motor and secretory responses to stress.Corticosterone mediates stress-related increased intestinal permeability in a region-specific manner.Stress management affects outcomes in the pathophysiology of an endometriosis model Expression of corticotropin releasing factor receptor type 1 (CRF1) in the human gastrointestinal tract and upregulation in the colonic mucosa in patients with ulcerative colitis.PKCγ receptor mediates visceral nociception and hyperalgesia following exposure to PTSD-like stress in the spinal cord of rats.Repeated Water Avoidance Stress Alters Mucosal Mast Cell Counts, Interleukin-1β Levels with Sex Differences in the Distal Colon of Wistar Rats.Sex hormones in the modulation of irritable bowel syndrome.Repeated otilonium bromide administration prevents neurotransmitter changes in colon of rats underwent to wrap restraint stress.Maternal separation as a model of brain-gut axis dysfunction.Corticotropin-releasing factor receptor type 1 and type 2 interaction in irritable bowel syndrome.Physiology of Visceral Pain.P2X3 receptor-mediated visceral hyperalgesia and neuronal sensitization following exposure to PTSD-like stress in the dorsal root ganglia of rats.Epithelial expression and function of trypsin-3 in irritable bowel syndrome.Characterization of Multisubstituted Corticotropin Releasing Factor (CRF) Peptide Antagonists (Astressins).Corticotropin-releasing Factor Changes the Phenotype and Function of Dendritic Cells in Mouse Mesenteric Lymph Nodes.Multi-center randomized controlled trial of cognitive treatment, placebo, oxybutynin, bladder training, and pelvic floor training in children with functional urinary incontinence.Novel insights in the role of peripheral corticotropin-releasing factor and mast cells in stress-induced visceral hypersensitivity.

P2860

Q28570004-8ACB4E77-6648-429F-AADD-677CF323AB4D Q30386276-FDA9F08C-841F-4902-B8C2-AB53B60AAE66 Q30421083-CF5532D2-C8A6-4CFF-8EB7-BBAD8AE4BB30 Q30459512-A7AA02F5-7696-410B-8D6D-9AEEF9399353 Q30464076-A2ACA838-68A0-4748-84DF-E099A27A0506 Q33624549-8D1D62CD-5C96-45E2-BEA1-253D524DACB3 Q34168517-4730394D-50E4-4923-9A28-7E7FD6840FC6 Q34510401-E37A8627-4570-47B1-AC2B-03ED3BF64E3B Q34882307-84FDAA5D-E03A-44DD-93E4-63BE75F99621 Q34989237-F5760915-DAFA-43AD-A155-A26377AFE743 Q35087100-CB3F859C-C838-4464-8D4D-CEFEF11B27F6 Q35161361-1EB2066B-BE8A-4277-97D9-90BF67A244FA Q35203621-E446C2E8-96F6-4AFA-88DE-4A2949EED049 Q35268662-FC4F9332-1731-444F-A678-A9DF4EB463D4 Q35558451-9828711C-08A3-4A49-AACB-1CE7A549F114 Q35681545-AAD011F7-CB7E-4239-89BE-E7586B7E11E6 Q35809342-8BB61CC9-B2F3-458B-A639-FBE489B3ACD3 Q35809350-43B37F60-CA29-400F-B6B3-2236CF56BDF9 Q35809355-CFF9AC3A-BEFF-4158-9871-51DDCA888710 Q35838055-DCD4C06C-073E-484D-AF21-E31FF83BFE56 Q35867820-B4391184-7DF4-4846-9640-1E5E2240E298 Q36144375-E1712800-DE47-428B-95A3-2D07A1A6F11C Q36315611-B494E7CF-25E5-484F-A413-3DCE49E9A499 Q36505484-1A6AC850-7F77-4A5A-87E3-7FD46B9AFD6F Q36573670-57D0A9C1-A7C9-4201-8782-E8813E4D99F0 Q36742630-A27D76FC-9F72-4745-AE77-FA7EB6D4C8AF Q36840740-0240C0CC-422A-4EAE-A9B1-F277177ED59B Q37116261-0CE756DC-AFFA-4C4E-806F-5B4DA7DB2822 Q37324440-B82D92CB-87FC-42B0-BB73-66646E4FEA49 Q37629667-496A0549-89E4-480F-851E-1ABAA90F12BD Q37693420-3DA00BC3-9324-445D-91D6-77AC92BC62E9 Q37795656-B8A24BDB-3B3D-4AEF-B11D-3DF9F58CF74C Q38473099-3777C5D6-5320-4FDF-8417-D1CE95B50D69 Q38991459-25233C39-D56A-4E43-9616-9680B8DA3326 Q39249530-8B28E5BC-7214-417D-A83E-525BC6B9C1BF Q39302488-9621B7DD-2297-49FF-A4FF-DE869378EE3F Q40084135-F14999A3-6100-4D1B-8F36-30321FC8BBDD Q42111830-74B2BF97-EA25-4792-A0EB-1F3631D19950 Q43767594-9A2E8A73-0014-41B6-AEEA-E7AC3B2751FD Q46285090-E36F8885-A42B-47F2-A39D-18962D9C1881

P2860

Cortagine, a CRF1 agonist, induces stresslike alterations of colonic function and visceral hypersensitivity in rodents primarily through peripheral pathways.

http://www.wikidata.org/entity/Q37264524

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 30 April 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Cortagine, a CRF1 agonist, ind ...... y through peripheral pathways.

@en

Cortagine, a CRF1 agonist, ind ...... y through peripheral pathways.

@nl

type

label

Cortagine, a CRF1 agonist, ind ...... y through peripheral pathways.

@en

Cortagine, a CRF1 agonist, ind ...... y through peripheral pathways.

@nl

prefLabel

Cortagine, a CRF1 agonist, ind ...... y through peripheral pathways.

@en

Cortagine, a CRF1 agonist, ind ...... y through peripheral pathways.

@nl

P1433

Q37264524-F9E69117-0D7D-4B6A-8D64-4E718E49A007

P1476

Q37264524-03427642-E435-4642-AF96-C3A5E0006717

P2093

Q37264524-9714B1F9-B89D-4DE6-BC08-6C6EE1DA12FC

Q37264524-99E68943-D881-4F88-993C-C39CD46A70CD

Q37264524-B4BCFB03-1118-40E6-92E4-24F45F57CB0B

Q37264524-C728BBB1-D002-42B2-9D04-D6616C7B1711

Q37264524-F3E0992A-C0C8-4CE0-8432-6CB835BE938B

P2860

Q37264524-011BDB15-1FED-4D78-B7AC-2B282FE4BC36

Q37264524-054F6CBB-685D-4CA9-9837-392A623BCEE5

Q37264524-07AC3F8F-FC52-4B0B-9035-742389B593DB

Q37264524-0CD4B391-8FDE-411E-BFF1-F22962E9B5D5

Q37264524-185133CB-B06D-4AF3-8789-FA3E3E245C06

Q37264524-1D516202-1582-4E8E-AD5B-9F169E5D2DC5

Q37264524-21FC43F9-8DB7-4D9A-8C51-2880B5EA8604

Q37264524-22903BAC-2899-4C69-9812-16CA1A1C1973

Q37264524-22B1AF97-6A8B-46D1-8967-DBDAA9693B4F

Q37264524-2D473DA9-6F43-4557-BD2E-FA623EFACC1C

P304

Q37264524-4ED00E9E-9733-4B51-AE74-6B5F99223D37

P31

Q37264524-8855DF1A-7986-4DD0-A6FB-C48C7A574E8B

P356

Q37264524-A17E8C3A-4041-497A-8C89-9132EE866428

P433

Q37264524-7A68A7A7-757C-4886-8E54-F8270DAE77BA

P478

Q37264524-5007F870-F85D-481B-BA3A-D6712C581BA7

P50

Q37264524-0149ADB6-AFCB-4657-8424-C0C991CFA6E5

Q37264524-03C64ED5-0E75-477F-9ABD-BFE771753800

Q37264524-528A87FD-3BD6-46A2-94CA-C425CB3DC07C

Q37264524-66DE0DB8-706C-4CE7-B389-BB6EEA7EE474

P577

Q37264524-B096877B-28BE-489F-B5F0-E53B3EED09A6

P5875

Q37264524-1323AB02-4206-44A1-8C8C-61003886B980

P698

Q37264524-A2953A2D-32A2-4BF0-940E-4D76FF882A63

P932

Q37264524-9BA40BCE-9888-4C50-B6FE-1EB5B8DE24CF

P356

AJPGI.00072.2009

P1433

American Journal of Physiology - Gastrointestinal and Liver Physiology

P1476

Cortagine, a CRF1 agonist, ind ...... y through peripheral pathways.

@en

P2093

David W Adelson

http://www.w3.org/2001/XMLSchema#string

Jean Rivier

http://www.w3.org/2001/XMLSchema#string

Karina Pambukchian

http://www.w3.org/2001/XMLSchema#string

Lixin Wang

http://www.w3.org/2001/XMLSchema#string

Stefan Brunnhuber

http://www.w3.org/2001/XMLSchema#string

P2860

Common and divergent structural features of a series of corticotropin releasing factor-related peptides

International Union of Pharmacology. XXXVI. Current status of the nomenclature for receptors for corticotropin-releasing factor and their ligands

Pathways involved in gut mucosal barrier dysfunction induced in adult rats by maternal deprivation: corticotrophin-releasing factor and nerve growth factor interplay

Neuroendocrine control of the gut during stress: corticotropin-releasing factor signaling pathways in the spotlight.

High-affinity CRF1 receptor antagonist NBI-34041: preclinical and clinical data suggest safety and efficacy in attenuating elevated stress response.

Peripheral corticotropin releasing factor (CRF) and a novel CRF1 receptor agonist, stressin1-A activate CRF1 receptor expressing cholinergic and nitrergic myenteric neurons selectively in the colon of conscious rats.

Corticotropin releasing factor receptors and their ligand family.

Types of neurons in the enteric nervous system.

Marked suppression of gastric ulcerogenesis and intestinal responses to stress by a novel class of drugs.

The pharmacology of CP-154,526, a non-peptide antagonist of the CRH1 receptor: a review.

P304

G215-27

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/AJPGI.00072.2009

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

297

http://www.w3.org/2001/XMLSchema#string

P50

Muriel Larauche

Mulugeta Million

Guillaume Gourcerol

P577

2009-04-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24394235

http://www.w3.org/2001/XMLSchema#string

P698

19407218

http://www.w3.org/2001/XMLSchema#string

P932

2711753

http://www.w3.org/2001/XMLSchema#string